BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 26272309)

  • 1. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
    Horton LG; Simmons KB; Curtis KM
    Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
    Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.
    Tepper NK; Phillips SJ; Kapp N; Gaffield ME; Curtis KM
    Contraception; 2016 Sep; 94(3):262-74. PubMed ID: 26002804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of hormonal contraceptives among women with migraine: A systematic review.
    Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
    Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review.
    Dragoman MV; Simmons KB; Paulen ME; Curtis KM
    Contraception; 2017 Feb; 95(2):117-129. PubMed ID: 27823942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.
    Roach RE; Helmerhorst FM; Lijfering WM; Stijnen T; Algra A; Dekkers OM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011054. PubMed ID: 26310586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestin-only contraception and thromboembolism: A systematic review.
    Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
    Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
    Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
    Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31711271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
    Cohen MA; Edelman A; Paynter R; Henderson JT
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014908. PubMed ID: 36622724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined Hormonal Contraception - Which Pill for Which Patient?].
    Quaas P
    Praxis (Bern 1994); 2023; 112(4):205-210. PubMed ID: 36919319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006133. PubMed ID: 24788670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
    Lopez LM; Grimes DA; Gallo MF; Stockton LL; Schulz KF
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD003552. PubMed ID: 23633314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006133. PubMed ID: 22513937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Types of progestogens in combined oral contraception: effectiveness and side-effects.
    Lawrie TA; Helmerhorst FM; Maitra NK; Kulier R; Bloemenkamp K; Gülmezoglu AM
    Cochrane Database Syst Rev; 2011 May; (5):CD004861. PubMed ID: 21563141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Plu-Bureau G; Sabbagh E; Hugon-Rodin J
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.